{"protocolSection": {"identificationModule": {"nctId": "NCT01486316", "orgStudyIdInfo": {"id": "IDENTIFY-HF"}, "organization": {"fullName": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}, "briefTitle": "Diagnostic Device Risk Management of Atrial Fibrillation and Heart Failure", "officialTitle": "Integrated Diagnostic Evaluation in Non-Therapy DevIces For the studY of Heart Failure", "acronym": "IDENTIFY-HF"}, "statusModule": {"statusVerifiedDate": "2018-06", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2011-11"}, "primaryCompletionDateStruct": {"date": "2014-12", "type": "ACTUAL"}, "completionDateStruct": {"date": "2015-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2011-11-04", "studyFirstSubmitQcDate": "2011-12-02", "studyFirstPostDateStruct": {"date": "2011-12-06", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2015-05-01", "resultsFirstSubmitQcDate": "2018-06-12", "resultsFirstPostDateStruct": {"date": "2018-07-12", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2018-06-12", "lastUpdatePostDateStruct": {"date": "2018-07-12", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "The purpose of this study is to characterize the feasibility and impact of a diagnostic tool that may help clinicians identify when patients are at higher risk of visiting the hospital for a heart failure event. The study will use a non-experimental device that is inserted just under the skin of the chest, which continuously monitors the heart rhythm in combination with an experimental web-based heart failure risk status. Patients with atrial fibrillation and heart failure will be evaluated to collect data about the potential of this risk status to help improve patient outcome."}, "conditionsModule": {"conditions": ["Atrial Fibrillation", "Heart Failure"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "DIAGNOSTIC", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 24, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Control arm", "type": "OTHER", "description": "Subjects in the Control arm will be observed between implant and month 12. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location). At month 12 through study close (month 18), study doctors for the all subjects will have access to the risk status.", "interventionNames": ["Device: Reveal XT\u00ae Insertable Cardiac Monitor", "Other: Heart Failure Risk Status Diagnostic"]}, {"label": "Risk Status Guided", "type": "EXPERIMENTAL", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).", "interventionNames": ["Device: Reveal XT\u00ae Insertable Cardiac Monitor", "Other: Heart Failure Risk Status Diagnostic"]}], "interventions": [{"type": "DEVICE", "name": "Reveal XT\u00ae Insertable Cardiac Monitor", "description": "If not previously implanted, a non-experimental insertable cardiac monitor will be implanted to collect information on the patients' heart condition as inputs into the heart failure risk status algorithm (during guided follow-up only, Guided arm: 6-18 months, Control arm: 12-18 months).", "armGroupLabels": ["Control arm", "Risk Status Guided"], "otherNames": ["Reveal XT\u00ae"]}, {"type": "OTHER", "name": "Heart Failure Risk Status Diagnostic", "description": "The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status and standard device trend data are provided to study doctors for remote management of their patients' heart failure using study specific protocols. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\".", "armGroupLabels": ["Control arm", "Risk Status Guided"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Correlation of Heart Failure Risk Score (HFRS) With Heart Failure Events", "description": "Evaluate the HFRS Algorithm prior to Heart Failure (HF) related clinical events among patients with HF and documented or suspected AF. Daily HFRS scores were calculated each day for each patient with an implanted Reveal XT device, and the scores were ordinal, with possible values of \"Low\", \"Medium\", \"High\", and \"Very High\". The objective was to assess the association between the daily scores before and after HF events (HF-related hospitalizations, clinic visits) among subjects experiencing such visits. This would only be done during follow-up periods in which physicians were blinded to the scores (see Time Frame). The score could only be generated if the subject performed a CareLink transmission of their device data during follow-up.\n\nBecause of the small number of subjects enrolled, formal statistical analyses were not performed. Subjects were partitioned by whether they (1) experienced a HF event, and (2) whether they experienced a High or Very High HFRS score.", "timeFrame": "0 to 6 months post-implant (HFRS Guided Arm), 0-12 months (Control Arm)"}], "otherOutcomes": [{"measure": "Correlation of HFRS Status With Actions/Testing", "description": "At scheduled visits in which the HFRS scores were available to clinicians, the scores were summarized, along with whether subjects experienced significant weight gain, high blood pressure, or reported heart failure symptoms.\n\nBecause of the small number of subjects randomized, no formal statistical analyses were performed.", "timeFrame": "6 to 18 months post-implant (HFRS Guided Arm), 13-18 months (Control Arm)"}, {"measure": "Clinical Status Measures", "description": "Characterize the difference in clinical status measures over time in each arm. Outcomes include Quality of Life (as measured by the Minnesota Living With Heart Failure Questionnaire, in which scores range from 0 (Best) to 105 (Worst), 6 Minute Hall Walk distance, and New York Heart Association (NYHA, ranging from Class I (Best) to Class IV (Worst))\n\nBecause of the small number of patients enrolled, formal statistical analyses were not performed and data were not summarized in aggregate.", "timeFrame": "0 to 18 months post-implant"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is 18 years of age or older\n* Patient (or patient's legally authorized representative) is willing and able to provide written informed consent\n* Patient is willing and able to comply with the protocol, including follow-up visits\n* Documented paroxysmal or persistent atrial fibrillation or strong suspicion of atrial fibrillation (i.e, palpitations)\n* Patient is indicated for the Reveal XT insertable cardiac monitor or other commercially-available and substantially equivalent Medtronic insertable cardiac monitor\n* Recent HF event within prior 120 days (HF event defined as meeting any one of the following two criteria: 1. Admission with primary diagnosis of HF 2. Intravenous HF therapy (e.g. IV diuretics/vasodilators) or ultrafiltration at any one of the following settings: admission with secondary/tertiary diagnosis of HF, emergency department, ambulance, observation unit, urgent care, HF/cardiology clinic, patient's home\n* Willing and able to transmit data via CareLink\n\nExclusion Criteria:\n\n* Patient is pregnant\n* Patient has been participating in another study that may interfere with the IDENTIFY-HF protocol required procedures\n* Endstage (Stage D or New York Heart Association class IV) heart failure\n* Asymptomatic (Stage B or New York Heart Association class I) heart failure\n* Severe aortic stenosis or insufficiency\n* Existing insertable cardiac monitor implanted for more than 1 year\n* Existing implantable pulse generator, implantable cardioverter defibrillator, cardiac resynchronization therapy device\n* Severe renal impairment (estimated glomerular filtration rate \\<25mL/min)\n* Myocardial infarction within prior 30 days", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "IDENTIFY-HF Team", "affiliation": "Medtronic", "role": "STUDY_CHAIR"}], "locations": [{"facility": "Scripps Green", "city": "La Jolla", "state": "California", "zip": "92037", "country": "United States", "geoPoint": {"lat": 32.84727, "lon": -117.2742}}, {"facility": "Aurora Denver Cardiology Associates", "city": "Aurora", "state": "Colorado", "zip": "80012", "country": "United States", "geoPoint": {"lat": 39.72943, "lon": -104.83192}}, {"facility": "Spectrum Health", "city": "Grand Rapids", "state": "Michigan", "zip": "49503", "country": "United States", "geoPoint": {"lat": 42.96336, "lon": -85.66809}}, {"facility": "The Valley Hospital", "city": "Ridgewood", "state": "New Jersey", "zip": "07450", "country": "United States", "geoPoint": {"lat": 40.97926, "lon": -74.11653}}, {"facility": "Carolinas Medical Center/Sanger Heart & Vascular", "city": "Charlotte", "state": "North Carolina", "zip": "28203", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"facility": "The Ohio State University", "city": "Columbus", "state": "Ohio", "zip": "43210", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"facility": "Lancaster Heart & Stroke Foundation", "city": "Lancaster", "state": "Pennsylvania", "zip": "17602", "country": "United States", "geoPoint": {"lat": 40.03788, "lon": -76.30551}}, {"facility": "Medical University of South Carolina", "city": "Charleston", "state": "South Carolina", "zip": "29425", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"facility": "St. Thomas Research Institute", "city": "Nashville", "state": "Tennessee", "zip": "37205", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"facility": "University of Texas Southwestern Medical Center", "city": "Dallas", "state": "Texas", "zip": "75390", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"facility": "Heart Clinic PLLC", "city": "McAllen", "state": "Texas", "zip": "78503", "country": "United States", "geoPoint": {"lat": 26.20341, "lon": -98.23001}}]}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Control Arm", "description": "The Control arm will be observed between implant and month 12. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location). At month 12 through study close (month 18), study doctors for the all subjects will have access to the risk status.\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "FG001", "title": "Risk Status Guided", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "FG002", "title": "No Implant", "description": "Subjects who did not undergo an implant attempt and were not randomized."}, {"id": "FG003", "title": "Implanted Not Randomized", "description": "Subject were implanted and not randomized"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "comment": "prior to study closure, 24 subjects were enrolled 7 subjects randomized to Control Arm", "numSubjects": "7"}, {"groupId": "FG001", "comment": "prior to study closure, 24 subjects were enrolled with 10 being randomized to HFRS Guided Arm", "numSubjects": "10"}, {"groupId": "FG002", "comment": "Exited prior to implant", "numSubjects": "5"}, {"groupId": "FG003", "comment": "Exited prior to 6 month visit", "numSubjects": "2"}]}, {"type": "COMPLETED", "comment": "18 Month/Exit Visit", "achievements": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "7"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "4"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "numSubjects": "2"}]}], "dropWithdraws": [{"type": "Device explanted with/without re-implant", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "2"}]}, {"type": "Not meeting eligibility criteria", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "3"}, {"groupId": "FG003", "numSubjects": "0"}]}, {"type": "Physician Decision", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Control Arm", "description": "Subjects in the Control arm will be observed between implant and month 12. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location). At month 12 through study close (month 18), study doctors for the all subjects will have access to the risk status.\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "BG001", "title": "Risk Status Guided", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "BG002", "title": "Not Randomized", "description": "Subjects who were not randomized"}, {"id": "BG003", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "7"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "24"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "74.9", "spread": "7.6"}, {"groupId": "BG001", "value": "66.2", "spread": "15.3"}, {"groupId": "BG002", "value": "70.3", "spread": "9.7"}, {"groupId": "BG003", "value": "69.9", "spread": "12.0"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "4"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "12"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "3"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "12"}]}]}]}, {"title": "Race (NIH/OMB)", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "American Indian or Alaska Native", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Asian", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Native Hawaiian or Other Pacific Islander", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Black or African American", "measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "1"}]}, {"title": "White", "measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "7"}, {"groupId": "BG003", "value": "23"}]}, {"title": "More than one race", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}, {"title": "Unknown or Not Reported", "measurements": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}, {"groupId": "BG003", "value": "0"}]}]}]}, {"title": "New York Heart Assocation (NYHA) Functional Classification", "description": "NYHA Class is a measure of a patient's degree of heart failure with 4 possible scores, ranging from I to IV. The classifications and 2015 definitions are as follows:\n\nI: No limitation of physical activity. II: Slight limitation of physical activity. Comfortable at rest. Ordinary physical activity results in fatigue, palpitation, dyspnea.\n\nIII: Marked limitation of physical activity. Comfortable at rest. Less than ordinary activity causes fatigue, palpitation, or dyspnea.\n\nIV: Unable to carry on any physical activity without discomfort. Symptoms of heart failure at rest.", "paramType": "NUMBER", "unitOfMeasure": "number", "classes": [{"title": "NYHA Class II", "categories": [{"measurements": [{"groupId": "BG000", "value": "5"}, {"groupId": "BG001", "value": "6"}, {"groupId": "BG002", "value": "3"}, {"groupId": "BG003", "value": "14"}]}]}, {"title": "NYHA Class III", "categories": [{"measurements": [{"groupId": "BG000", "value": "2"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "4"}, {"groupId": "BG003", "value": "10"}]}]}]}, {"title": "LVEF", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "percentage", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "60.0", "spread": "4.1"}, {"groupId": "BG001", "value": "60.2", "spread": "10.7"}, {"groupId": "BG002", "value": "50.6", "spread": "11.6"}, {"groupId": "BG003", "value": "57.3", "spread": "10.2"}]}]}]}, {"title": "Heart Failure Stage", "paramType": "NUMBER", "unitOfMeasure": "Participants", "classes": [{"title": "Stage C", "categories": [{"measurements": [{"groupId": "BG000", "value": "6"}, {"groupId": "BG001", "value": "9"}, {"groupId": "BG002", "value": "5"}, {"groupId": "BG003", "value": "20"}]}]}, {"title": "Not available", "categories": [{"measurements": [{"groupId": "BG000", "value": "1"}, {"groupId": "BG001", "value": "1"}, {"groupId": "BG002", "value": "2"}, {"groupId": "BG003", "value": "4"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Correlation of Heart Failure Risk Score (HFRS) With Heart Failure Events", "description": "Evaluate the HFRS Algorithm prior to Heart Failure (HF) related clinical events among patients with HF and documented or suspected AF. Daily HFRS scores were calculated each day for each patient with an implanted Reveal XT device, and the scores were ordinal, with possible values of \"Low\", \"Medium\", \"High\", and \"Very High\". The objective was to assess the association between the daily scores before and after HF events (HF-related hospitalizations, clinic visits) among subjects experiencing such visits. This would only be done during follow-up periods in which physicians were blinded to the scores (see Time Frame). The score could only be generated if the subject performed a CareLink transmission of their device data during follow-up.\n\nBecause of the small number of subjects enrolled, formal statistical analyses were not performed. Subjects were partitioned by whether they (1) experienced a HF event, and (2) whether they experienced a High or Very High HFRS score.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "0 to 6 months post-implant (HFRS Guided Arm), 0-12 months (Control Arm)", "groups": [{"id": "OG000", "title": "Control Arm", "description": "The Control arm will be observed between months 13-18. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location), but study doctors for the subjects will have access to the risk status.\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "OG001", "title": "Risk Status Guided", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "10"}]}], "classes": [{"title": "High/Very High Score & HF Event(s)", "categories": [{"measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "High/Very High Score, No HF Event(s)", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "7"}]}]}, {"title": "HF Event(s), No High/Very High Score", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "No High/Very High Score or HF Event(s)", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Correlation of HFRS Status With Actions/Testing", "description": "At scheduled visits in which the HFRS scores were available to clinicians, the scores were summarized, along with whether subjects experienced significant weight gain, high blood pressure, or reported heart failure symptoms.\n\nBecause of the small number of subjects randomized, no formal statistical analyses were performed.", "populationDescription": "Only randomized subjects who did not exit prior to the period in which clinicians could utilized the HFRS score (6-18 months for HFRS Guided Arm, 13-18 months for Control Arm) were included in the analysis.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Visits with high/very high score", "timeFrame": "6 to 18 months post-implant (HFRS Guided Arm), 13-18 months (Control Arm)", "typeUnitsAnalyzed": "Visits with High/Very High HFRS Score", "denomUnitsSelected": "Visits with High/Very High HFRS Score", "groups": [{"id": "OG000", "title": "Control Arm", "description": "The Control arm will be observed between months 13-18, and so only the subjects followed beyond 12 months are included in the analysis. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location), but study doctors for the subjects will have access to the risk status.\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "OG001", "title": "Risk Status Guided", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "10"}]}, {"units": "Visits with High/Very High HFRS Score", "counts": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "58"}]}], "classes": [{"title": "Significant Weight Gain Reported", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "9"}]}]}, {"title": "High Blood Pressure", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "5"}]}]}, {"title": "HF Symptoms Reported", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "46"}]}]}, {"title": "Medications Adjusted due to HFRS Score", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "18"}]}]}, {"title": "Rate Control Meds Adjusted due to HFRS Score", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Blood Pressure Meds Adjusted due to HFRS Score", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "4"}]}]}, {"title": "Diuretics Adjusted due to HFRS Score", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "15"}]}]}, {"title": "Directed to Clinic", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "9"}]}]}, {"title": "Directed to Emergency Department", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Directed to Hospital", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Clinical Status Measures", "description": "Characterize the difference in clinical status measures over time in each arm. Outcomes include Quality of Life (as measured by the Minnesota Living With Heart Failure Questionnaire, in which scores range from 0 (Best) to 105 (Worst), 6 Minute Hall Walk distance, and New York Heart Association (NYHA, ranging from Class I (Best) to Class IV (Worst))\n\nBecause of the small number of patients enrolled, formal statistical analyses were not performed and data were not summarized in aggregate.", "populationDescription": "Subjects randomized to the Risk Status Guided Arm", "reportingStatus": "POSTED", "paramType": "COUNT_OF_UNITS", "unitOfMeasure": "Outcome of Patients During Guided Period", "calculatePct": false, "timeFrame": "0 to 18 months post-implant", "typeUnitsAnalyzed": "Outcome of Patients During Guided Period", "denomUnitsSelected": "Outcome of Patients During Guided Period", "groups": [{"id": "OG000", "title": "Risk Status Guided", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}, {"id": "OG001", "title": "Control Arm", "description": "The Control arm will be observed between months 13-18, and so only Control arm subjects followed beyond 12 months are included. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location), but study doctors for the subjects will have access to the risk status.\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\"."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "10"}, {"groupId": "OG001", "value": "4"}]}, {"units": "Outcome of Patients During Guided Period", "counts": [{"groupId": "OG000", "value": "25"}, {"groupId": "OG001", "value": "2"}]}], "classes": [{"categories": [{"title": "HF Event During Guided Period", "measurements": [{"groupId": "OG000", "value": "6"}, {"groupId": "OG001", "value": "1"}]}, {"title": "High/Very High HFRS Score During Guided Period", "measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "1"}]}, {"title": "Quality of Life Improvement During Guided Period", "measurements": [{"groupId": "OG000", "value": "5"}, {"groupId": "OG001", "value": "0"}]}, {"title": "6 Minute Hall Walk Improved During Guided Period", "measurements": [{"groupId": "OG000", "value": "3"}, {"groupId": "OG001", "value": "0"}]}, {"title": "Improved NYHA During Guided Period", "measurements": [{"groupId": "OG000", "value": "4"}, {"groupId": "OG001", "value": "0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "Adverse events were collected from the point of enrollment to the completion of follow-up (18 months).", "description": "All subjects were assessed for adverse events through their follow-up visits as well as unscheduled visits as the adverse events occurred.", "eventGroups": [{"id": "EG000", "title": "Control Arm", "description": "Subjects in the Control arm will be observed between implant and month 12. During this time, the standard device diagnostic suite will be used as it would normally, in the office using the programmer, or by data transmission from the patient's home (or another remote location). At month 12 through study close (month 18), study doctors for the all subjects will have access to the risk status.\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status.The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\".", "deathsNumAffected": 0, "deathsNumAtRisk": 7, "seriousNumAffected": 6, "seriousNumAtRisk": 7, "otherNumAffected": 6, "otherNumAtRisk": 7}, {"id": "EG001", "title": "Risk Status Guided", "description": "Study doctors will have access to the experimental IDENTIFY-HF Risk Status for subjects in the Guided arm between months 6 and 18. At all times during the study, study doctors will also be able to use the standard device diagnostics in the office using the programmer, or by data transmission from the patient's home (or another remote location).\n\nHeart Failure Risk Status Diagnostic: The experimental IDENTIFY-HF Risk Status developed for this study will be used to change standard device data to a heart failure risk status. The risk status inputs are: night heart rate, heart rate variability, atrial fibrillation burden, ventricular rate during atrial fibrillation, patient activity.\n\nBased on pre-defined thresholds for each of the above inputs, as well as data trends, a heart failure score is derived. The heart failure score is then classified as: \"Low\", \"Medium\", \"High\", or \"Very High\".", "deathsNumAffected": 0, "deathsNumAtRisk": 10, "seriousNumAffected": 5, "seriousNumAtRisk": 10, "otherNumAffected": 7, "otherNumAtRisk": 10}], "seriousEvents": [{"term": "Acute Myocardial Infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Unstable Angina", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Atrial Fribrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 3, "numAffected": 2, "numAtRisk": 10}]}, {"term": "Cardiac Failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 10}]}, {"term": "Chest Pain", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Deep Vein Thrombosis", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "International normalizes ratio decreased", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Pneumonia", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Pulmonary Vascular Disorder", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Sick Sinus Syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Acute Respiratory Failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Cardiac Arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Cardogenic Shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Cardiomyopathy", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Renal Failure Acute", "organSystem": "Endocrine disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 3, "numAffected": 1, "numAtRisk": 10}]}], "otherEvents": [{"term": "Atrial Fribillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 4, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 10}]}, {"term": "Cardiac Failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 3, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 3, "numAffected": 3, "numAtRisk": 10}]}, {"term": "Drug Intolerance", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Hyperkalaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Palpitations", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 10}]}, {"term": "Bradycardia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Chest Discomfort", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Cough", "organSystem": "General disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Syncope", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 10}]}, {"term": "Cardiac Failure Congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA (17.1)", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 7}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 10}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Rachael Rose, Clinical Research Specialist", "organization": "Medtronic, Inc", "email": "rachael.k.rose@medtronic.com", "phone": "763-526-2332"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000001281", "term": "Atrial Fibrillation"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}, {"id": "D000001145", "term": "Arrhythmias, Cardiac"}, {"id": "D000010335", "term": "Pathologic Processes"}], "browseLeaves": [{"id": "M4586", "name": "Atrial Fibrillation", "asFound": "Atrial Fibrillation", "relevance": "HIGH"}, {"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "M4453", "name": "Arrhythmias, Cardiac", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "BC23", "name": "Symptoms and General Pathology"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}